Hospitalizations among people with Down syndrome: A nationwide population-based study in Denmark

American Journal of Medical Genetics, Part A

Volumn 161, Issue 4, 2013, Pages 650-657

  Zhu, Jin Liang ^a   Hasle, Henrik ^b   Correa, Adolfo ^c,d   Schendel, Diana ^c   Friedman, J M ^e   Olsen, Jørn ^a   Rasmussen, Sonja A ^c  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Comorbidity; Congenital heart defects; Down syndrome; Hospitalization; Register

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DENMARK; DISEASE REGISTRY; DOWN SYNDROME; FEMALE; HOSPITAL ADMISSION; HOSPITAL BED; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NEOPLASM; NEUROLOGIC DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SENSORY DYSFUNCTION; SURVIVAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; DENMARK; DOWN SYNDROME; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; REGISTRIES; YOUNG ADULT;

EID: 84875486933     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35711     Document Type: Article

References (38)

1. Anwar AJ, Walker JD, Frier BM. 1998. Type 1 diabetes mellitus and Down's syndrome: Prevalence, management and diabetic complications. Diabet Med 15:160-163.
2. Bittles AH, Bower C, Hussain R, Glasson EJ. 2007. The four ages of Down syndrome. Eur J Public Health 17:221-225.
3. Bittles AH, Glasson EJ. 2004. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol 46:282-286.
4. Cohen WI. 2006. Current dilemmas in Down syndrome clinical care: Celiac disease, thyroid disorders, and atlanto-axial instability. Am J Med Genet C Semin Med Genet 142C:141-148.
5. Esbensen AJ. 2010. Health conditions associated with aging and end of life of adults with Down syndrome. Int Rev Res Ment Retard 39:107-126.
6. Freeman SB, Bean LH, Allen EG, Tinker SW, Locke AE, Druschel C, Hobbs CA, Romitti PA, Royle MH, Torfs CP, Dooley KJ, Sherman SL. 2008. Ethnicity, sex, and the incidence of congenital heart defects: A report from the National Down Syndrome Project. Genet Med 10:173-180.
7. Freeman SB, Torfs CP, Romitti PA, Royle MH, Druschel C, Hobbs CA, Sherman SL. 2009. Congenital gastrointestinal defects in Down syndrome: A report from the Atlanta and National Down Syndrome Projects. Clin Genet 75:180-184.
8. Frid C, Anneren G, Rasmussen F, Sundelin C, Drott P. 2002. Utilization of medical care among children with Down's syndrome. J Intellect Disabil Res 46:310-317.
9. Goldstein H. 1988a. Utilisation of health services over a one-year period by an adolescent population with Down syndrome. Dan Med Bull 35:585-588.
10. Goldstein H. 1988b. Utilisation of health services over a one-year period by an adult population with Down syndrome. Dan Med Bull 35:100-104.
11. Hasle H, Clemmensen IH, Mikkelsen M. 2000. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355:165-169.
12. Henderson A, Lynch SA, Wilkinson S, Hunter M. 2007. Adults with Down's syndrome: The prevalence of complications and health care in the community. Br J Gen Pract 57:50-55.
13. Hilton JM, Fitzgerald DA, Cooper DM. 1999. Respiratory morbidity of hospitalized children with Trisomy 21. J Paediatr Child Health 35:383-386.
14. Hung WJ, Lin LP, Wu CL, Lin JD. 2011. Cost of hospitalization and length of stay in people with Down syndrome: Evidence from a national hospital discharge claims database. Res Dev Disabil 32:1709-1713.
15. Interior and Health Ministry. 2007. Sundhedssektoren i tal [The Health Sector in Figures]. Copenhagen: Interior and Health Ministry, Office of Health Statistics. p 27.
16. Kerins G, Petrovic K, Bruder MB, Gruman C. 2008. Medical conditions and medication use in adults with Down syndrome: A descriptive analysis. Downs Syndr Res Pract 12:141-147.
17. Leonard S, Bower C, Petterson B, Leonard H. 1999. Medical aspects of school-aged children with Down syndrome. Dev Med Child Neurol 41:683-688.
18. Lin DY, Wei LJ. 1989. The Robust Inference for the Cox Proportional Hazards Model. J Am Stat Assoc 84:1074-1078.
19. Nespoli L, Burgio GR, Ugazio AG, Maccario R. 1993. Immunological features of Down's syndrome: A review. J Intellect Disabil Res 37:543-551.
20. Nielsen J. 1980. The Danish Cytogenetic Central Register: Organization and results. Topics in human genetics. Stuttgart: Georg Thieme. p 86
21. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS, Correa A. 2010. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88:1008-1016.
22. Patja K, Pukkala E, Sund R, Iivanainen M, Kaski M. 2006. Cancer incidence of persons with Down syndrome in Finland: A population-based study. Int J Cancer 118:1769-1772.
23. Rasmussen SA, Whitehead N, Collier SA, Frias JL. 2008. Setting a public health research agenda for Down syndrome: Summary of a meeting sponsored by the Centers for Disease Control and Prevention and the National Down Syndrome Society. Am J Med Genet Part A 146A:2998-3010.
24. Rasmussen SA, Wong LY, Correa A, Gambrell D, Friedman JM. 2006. Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998. J Pediatr 148:806-812.
25. Schieve LA, Boulet SL, Boyle C, Rasmussen SA, Schendel D. 2009. Health of children 3-17 years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics 123:e253-e260.
26. Schieve LA, Boulet SL, Kogan MD, Van Naarden-Braun K, Boyle CA. 2011. A population-based assessment of the health, functional status, and consequent family impact among children with Down syndrome. Disabil Health J 4:68-77.
27. Shin M, Siffel C, Correa A. 2010. Survival of children with mosaic Down syndrome. Am J Med Genet Part A 152A:800-801.
28. Shott SR. 2006. Down syndrome: Common otolaryngologic manifestations. Am J Med Genet C Semin Med Genet 142C:131-140.
29. So SA, Urbano RC, Hodapp RM. 2007. Hospitalizations of infants and young children with Down syndrome: Evidence from inpatient person-records from a statewide administrative database. J Intellect Disabil Res 51:1030-1038.
30. Tenenbaum A, Chavkin M, Wexler ID, Korem M, Merrick J. 2012. Morbidity and hospitalizations of adults with Down syndrome. Res Dev Disabil 33:435-441.
31. Thomas K, Bourke J, Girdler S, Bebbington A, Jacoby P, Leonard H. 2011. Variation over time in medical conditions and health service utilization of children with Down syndrome. J Pediatr 158:194-200.
32. Torfs CP, Christianson RE. 1998. Anomalies in Down syndrome individuals in a large population-based registry. Am J Med Genet 77:431-438.
33. Turner S, Sloper P, Cunningham C, Knussen C. 1990. Health problems in children with Down's syndrome. Child Care Health Dev 16:83-97.
34. van Allen MI, Fung J, Jurenka SB. 1999. Health care concerns and guidelines for adults with Down syndrome. Am J Med Genet 89:100-110.
35. van Trotsenburg AS, Heymans HS, Tijssen JG, de Vijlder JJ, Vulsma T. 2006. Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome. Pediatrics 118:1633-1639.
36. Yang Q, Rasmussen SA, Friedman JM. 2002. Mortality associated with Down's syndrome in the USA from 1983 to 1997: A population-based study. Lancet 359:1019-1025.
37. Zigman WB, Lott IT. 2007. Alzheimer's disease in Down syndrome: Neurobiology and risk. Ment Retard Dev Disabil Res Rev 13:237-246.
38. Zwaan MC, Reinhardt D, Hitzler J, Vyas P. 2008. Acute leukemias in children with Down syndrome. Pediatr Clin North Am 55:53-70.